gRNA市場-規模、シェア、動向分析レポート、およびセグメント予測、2024〜2030

レポートナンバー　0000037137

バイオ・ゲノム・再生医療

gRNA市場-規模、シェア、動向分析レポート、およびセグメント予測、2024〜2030

Grand View Research Inc.

gRNA Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2024- 2030

発刊日 2024/01

言語英語

体裁PDF/110ページ

ライセンス/価格110ページ

0000037137

Individual	5,950USD
Team	6,950USD
Enterprise	8,950USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

お問い合わせ

サンプル依頼

無料サンプル

サンプルはお問い合わせください。

レポート概要

gRNAの市場規模、シェア、動向分析レポート:製品・サービス別(製品、カスタムgRNA合成サービス)、gRNAタイプ別(研究用)、用途別、最終用途別、地域別、セグメント別予測(2024-2030年)

gRNAの市場規模と動向

gRNAの世界市場の規模は、2023年に4億9,790万ドルと推定され、2024年から2030年にかけて18.6%のCAGRで成長すると予測されます。gRNAは、CRISPRベースの遺伝子編集において極めて重要な役割を果たすため、高い需要があります。CRISPRシステムは、特定のDNA配列に誘導する独自の能力を備えているため、精密な遺伝子編集に不可欠なツールとなっています。研究者や科学者は、gRNAを利用して遺伝子を正確に標的とし、遺伝子を改変し、医学、農業、バイオテクノロジーの画期的な進歩を可能にしています。その汎用性、精度、効率性は、遺伝性疾患の潜在的な治療法、革新的な農業慣行、および基本的な生物学的プロセスの研究を約束し、その需要を促進しています。標的遺伝子組み換えの探求が進む中、gRNAは依然として遺伝子研究を推進するための人気コンポーネントとなっています。

レポート詳細

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.2. Information Analysis
1.3. Market Formulation & Data Visualization
1.4. Data Validation & Publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

Chapter 2. gRNA Market: Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. gRNA Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Increase in adoption of Next-Generation Sequencing
3.4.2. Growing R&D in proteomics and genomics
3.4.3. Increasing adoption of personalized medicine
3.5. Market Restraint Analysis
3.5.1. Regulatory Challenges
3.5.2. Off-Target Effects and Safety Concerns
3.6. Business Environment Analysis
3.6.1. Porter’s Five Forces Analysis
3.6.2. PESTLE Analysis
3.7. COVID-19 Analysis

Chapter 4. Product & Services Estimates & Trend Analysis
4.1. gRNA market: Product & Services Movement Analysis
4.2. Products
4.2.1. Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.2. gRNA Final Products
4.2.2.1. gRNA Final Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.3. gRNA Synthesis Products
4.2.3.1. gRNA Synthesis Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.3.2. gRNA Synthesis Kits
4.2.3.2.1. gRNA Synthesis Kits Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.3.3. Plasmids
4.2.3.3.1. Plasmids Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.3.4. Others
4.2.3.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3. Custom gRNA Synthesis Services
4.3.1. Custom gRNA Synthesis Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. gRNA Type Estimates & Trend Analysis
5.1. gRNA market: gRNA Type Movement Analysis
5.2. Research-Use
5.2.1. Research-Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3. GMP-grade
5.3.1. GMP-grade Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Application Estimates & Trend Analysis
6.1. gRNA market: Application Movement Analysis
6.2. Genome Engineering
6.2.1. Genome Engineering Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Disease Model Studies
6.3.1. Disease Model Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Functional Genomics
6.4.1. Functional Genomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Epigenetics
6.5.1. Epigenetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. End-Use Estimates & Trend Analysis
7.1. gRNA market: End-Use Movement Analysis
7.2. Pharmaceutical & Biotechnology Companies
7.2.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Academic Research Institutes
7.3.1. Academic Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. CMOs & CROs
7.4.1. CMOs & CROs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis
8.1. Regional Market Snapshot
8.2. North America
8.2.1. North America gRNA Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Competitive Scenario
8.2.2.3. Regulatory Framework
8.2.2.4. Target Disease Prevalence
8.2.2.5. U.S. gRNA Market, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Competitive Scenario
8.2.3.3. Regulatory Framework
8.2.3.4. Target Disease Prevalence
8.2.3.5. Canada gRNA Market, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe gRNA Market, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. Target Disease Prevalence
8.3.2.5. UK gRNA Market, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Target Disease Prevalence
8.3.3.5. Germany gRNA Market, 2018 - 2030 (USD Million)
8.3.4. Spain
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. Target Disease Prevalence
8.3.4.5. Spain gRNA Market, 2018 - 2030 (USD Million)
8.3.5. France
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Framework
8.3.5.4. Target Disease Prevalence
8.3.5.5. France gRNA Market, 2018 - 2030 (USD Million)
8.3.6. Italy
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Framework
8.3.6.4. Target Disease Prevalence
8.3.6.5. Italy gRNA Market, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Regulatory Framework
8.3.7.4. Target Disease Prevalence
8.3.7.5. Denmark gRNA Market, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Regulatory Framework
8.3.8.4. Target Disease Prevalence
8.3.8.5. Sweden gRNA Market, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Regulatory Framework
8.3.9.4. Target Disease Prevalence
8.3.9.5. Norway gRNA Market, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia-Pacific gRNA Market, 2018 - 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. Target Disease Prevalence
8.4.2.5. Japan gRNA Market, 2018 - 2030 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Target Disease Prevalence
8.4.3.5. China gRNA Market, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. Target Disease Prevalence
8.4.4.5. India gRNA Market, 2018 - 2030 (USD Million)
8.4.5. South Korea
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Target Disease Prevalence
8.4.5.5. South Korea gRNA Market, 2018 - 2030 (USD Million)
8.4.6. Thailand
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Target Disease Prevalence
8.4.6.5. Thailand gRNA Market, 2018 - 2030 (USD Million)
8.4.7. Australia
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Target Disease Prevalence
8.4.7.5. Australia gRNA Market, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America gRNA Market, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Target Disease Prevalence
8.5.2.5. Brazil gRNA Market, 2018 - 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Target Disease Prevalence
8.5.3.5. Mexico gRNA Market, 2018 - 2030 (USD Million)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. Target Disease Prevalence
8.5.4.5. Argentina gRNA Market, 2018 - 2030 (USD Million)
8.6. MEA
8.6.1. MEA gRNA Market, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Target Disease Prevalence
8.6.2.5. South Africa gRNA Market, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Target Disease Prevalence
8.6.3.5. Saudi Arabia gRNA Market, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Target Disease Prevalence
8.6.4.5. UAE gRNA Market, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Target Disease Prevalence
8.6.5.5. Kuwait gRNA Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.2.1. Acquisition
9.2.2. Product/service launch
9.2.3. Partnerships/Collaborations
9.2.4. Others
9.3. Market Position Analysis, 2023
9.4. Company Profiles
9.4.1. Thermo Fisher Scientififc, Inc
9.4.1.1. Company Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Agilent Technologies, Inc.
9.4.2.1. Company Overview
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. System Biosciences, LLC.
9.4.3.1. Company Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Jena Bioscience GmbH
9.4.4.1. Company Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Merck KGaA
9.4.5.1. Company Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Azenta Life Sciences (Genewiz)
9.4.6.1. Company Overview
9.4.6.2. Product Benchmarking
9.4.6.3. Strategic Initiatives
9.4.7. Takara Bio Inc.
9.4.7.1. Company Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Synbio Technologies
9.4.8.1. Company Overview
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Revvity Inc (Horizon Discovery Ltd.)
9.4.9.1. Company Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Synthego
9.4.10.1. Company Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives

List of Tables
TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Global gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 4 Global gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 5 Global gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 6 Global gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 7 Global gRNA market, by Region, 2018 - 2030 (USD Million)
TABLE 8 North America gRNA market, by Country, 2018 - 2030 (USD Million)
TABLE 9 North America gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 10 North America gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 11 North America gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 12 North America gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 13 U.S. gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 14 U.S. gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 15 U.S. gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 16 U.S. gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 17 Canada gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 18 Canada gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 19 Canada gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 20 Canada gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 21 Europe gRNA market, by Country, 2018 - 2030 (USD Million)
TABLE 22 Europe gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 23 Europe gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 24 Europe gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 25 Europe gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 26 UK gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 27 UK gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 28 UK gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 29 UK gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 30 Germany gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 31 Germany gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 32 Germany gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 33 Germany gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 34 France gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 35 France gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 36 France gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 37 France gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 38 Italy gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 39 Italy gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 40 Italy gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 41 Italy gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 42 Spain gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 43 Spain gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 44 Spain gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 45 Spain gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 46 Sweden gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 47 Sweden gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 48 Sweden gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 49 Sweden gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 50 Norway gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 51 Norway gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 52 Norway gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 53 Norway gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 54 Denmark gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 55 Denmark gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 56 Denmark gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 57 Denmark gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 58 Asia Pacific gRNA market, by Country, 2018 - 2030 (USD Million)
TABLE 59 Asia Pacific gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 60 Asia Pacific gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 61 Asia Pacific gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 62 Asia Pacific gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 63 Japan gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 64 Japan gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 65 Japan gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 66 Japan gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 67 China gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 68 China gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 69 China gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 70 China gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 71 India gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 72 India gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 73 India gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 74 India gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 75 Australia gRNA arket, by Product & Services, 2018 - 2030 (USD Million)
TABLE 76 Australia gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 77 Australia gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 78 Australia gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 79 South Korea gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 80 South Korea gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 81 South Korea gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 82 South Korea gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 83 Thailand gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 84 Thailand gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 85 Thailand gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 86 Thailand gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 87 Latin America gRNA market, by Country, 2018 - 2030 (USD Million)
TABLE 88 Latin America gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 89 Latin America gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 90 Latin America gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 91 Latin America gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 92 Brazil gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 93 Brazil gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 94 Brazil gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 95 Brazil gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 96 Mexico gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 97 Mexico gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 98 Mexico gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 99 Mexico gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 100 Argentina gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 101 Argentina gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 102 Argentina gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 103 Argentina gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 104 MEA gRNA market, by Country, 2018 - 2030 (USD Million)
TABLE 105 MEA gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 106 MEA gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 107 MEA gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 108 MEA gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 109 South Africa gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 110 South Africa gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 111 South Africa gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 112 South Africa gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 113 Saudi Arabia gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 114 Saudi Arabia gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 115 Saudi Arabia gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 116 Saudi Arabia gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 117 UAE gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 118 UAE gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 119 UAE gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 120 UAE gRNA market, by End-Use, 2018 - 2030 (USD Million)
TABLE 121 Kuwait gRNA market, by Product & Services, 2018 - 2030 (USD Million)
TABLE 122 Kuwait gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
TABLE 123 Kuwait gRNA market, by Application, 2018 - 2030 (USD Million)
TABLE 124 Kuwait gRNA market, by End-Use, 2018 - 2030 (USD Million)

List of Figures
FIG. 1 Market Research Process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 gRNA market Segmentation
FIG. 8 Market Snapshot, 2023
FIG. 9 Market Trends & Outlook
FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 12 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
FIG. 13 Porter’s Five Forces Analysis
FIG. 14 Market Penetration & Growth Prospect Mapping, 2023
FIG. 15 Global gRNA market: Product & Services Movement Analysis
FIG. 16 Global gRNA market, For Products, 2018 - 2030 (USD Million)
FIG. 17 Global gRNA market, For gRNA Final Products, 2018 - 2030 (USD Million)
FIG. 18 Global gRNA market, For gRNA Synthesis Products, 2018 - 2030 (USD Million)
FIG. 19 Global gRNA market, For gRNA Synthesis Kits, 2018 - 2030 (USD Million)
FIG. 20 Global gRNA market, For Plasmids, 2018 - 2030 (USD Million)
FIG. 21 Global gRNA market, For Others, 2018 - 2030 (USD Million)
FIG. 22 Global gRNA market, For Custom gRNA Synthesis Services, 2018 - 2030 (USD Million)
FIG. 23 Global gRNA market: gRNA Type Movement Analysis
FIG. 24 Global gRNA market, For Research-Use, 2018 - 2030 (USD Million)
FIG. 25 Global gRNA market, For GMP-grade, 2018 - 2030 (USD Million)
FIG. 26 Global gRNA market: Application Movement Analysis
FIG. 27 Global gRNA market, For Genome Engineering, 2018 - 2030 (USD Million)
FIG. 28 Global gRNA market, For Disease Model Studies, 2018 - 2030 (USD Million)
FIG. 29 Global gRNA market, For Functional Genomics, 2018 - 2030 (USD Million)
FIG. 30 Global gRNA market, For Epigenetics, 2018 - 2030 (USD Million)
FIG. 31 Global gRNA market, For Others, 2018 - 2030 (USD Million)
FIG. 32 Global gRNA market: End-Use Movement Analysis
FIG. 33 Global gRNA market, For Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
FIG. 34 Global gRNA market, For Academic Research Institutes, 2018 - 2030 (USD Million)
FIG. 35 Global gRNA market, For CMOs & CROs, 2018 - 2030 (USD Million)
FIG. 36 Regional Marketplace: Key Takeaways
FIG. 37 Regional Outlook, 2023 & 2030
FIG. 38 Global gRNA market: Region Movement Analysis
FIG. 39 North America gRNA market, 2018 - 2030 (USD Million)
FIG. 40 U.S. gRNA market, 2018 - 2030 (USD Million)
FIG. 41 Canada gRNA market, 2018 - 2030 (USD Million)
FIG. 42 Europe gRNA market, 2018 - 2030 (USD Million)
FIG. 43 Germany gRNA market, 2018 - 2030 (USD Million)
FIG. 44 UK gRNA market, 2018 - 2030 (USD Million)
FIG. 45 France gRNA market, 2018 - 2030 (USD Million)
FIG. 46 Italy gRNA market, 2018 - 2030 (USD Million)
FIG. 47 Spain gRNA market, 2018 - 2030 (USD Million)
FIG. 48 Denmark gRNA market, 2018 - 2030 (USD Million)
FIG. 49 Sweden gRNA market, 2018 - 2030 (USD Million)
FIG. 50 Norway gRNA market, 2018 - 2030 (USD Million)
FIG. 51 Asia Pacific gRNA market, 2018 - 2030 (USD Million)
FIG. 52 Japan gRNA market, 2018 - 2030 (USD Million)
FIG. 53 China gRNA market, 2018 - 2030 (USD Million)
FIG. 54 India gRNA market, 2018 - 2030 (USD Million)
FIG. 55 Australia gRNA market, 2018 - 2030 (USD Million)
FIG. 56 South Korea gRNA market, 2018 - 2030 (USD Million)
FIG. 57 Thailand gRNA market, 2018 - 2030 (USD Million)
FIG. 58 Latin America gRNA market, 2018 - 2030 (USD Million)
FIG. 59 Brazil gRNA market, 2018 - 2030 (USD Million)
FIG. 60 Mexico gRNA market, 2018 - 2030 (USD Million)
FIG. 61 Argentina gRNA market, 2018 - 2030 (USD Million)
FIG. 62 Middle East And Africa gRNA market, 2018 - 2030 (USD Million)
FIG. 63 South Africa gRNA market, 2018 - 2030 (USD Million)
FIG. 64 Saudi Arabia gRNA market, 2018 - 2030 (USD Million)
FIG. 65 UAE gRNA market, 2018 - 2030 (USD Million)
FIG. 66 Kuwait gRNA market, 2018 - 2030 (USD Million)

お買い物ガイド

よくある質問

この商品のレポートナンバー

0000037137

国内・海外の市場調査レポート販売

世界中の市場調査レポートを販売！当社に無いレポートもお探しします。